InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: palm post# 7299

Tuesday, 05/28/2013 12:35:59 PM

Tuesday, May 28, 2013 12:35:59 PM

Post# of 428163
That is totally different than original report that said
"said in a lecture that there is no reason to give Vascepa to patients with triglyceride levels below 500 "

The full text does not say that at all, seems more an answer to a question about Anchor population. The jump to " their opinion that the FDA will not approve " which is not even related to what the person said in this statement.

Seems Summer Street is shorting and using a vague statement to sound worse than reality
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News